KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)R&D In ProcessReceivables - NetShares Repurchased
Ratios

Jazz Pharmaceuticals (JAZZ) Shares Repurchased (2016 - 2024)

Jazz Pharmaceuticals has reported Shares Repurchased over the past 10 years, most recently at $150.0 million for Q3 2024.

  • Quarterly results put Shares Repurchased at $150.0 million for Q3 2024, up 101.69% from a year ago — trailing twelve months through Dec 2025 was $150.0 million (down 53.73% YoY), and the annual figure for FY2025 was $125.0 million, down 59.86%.
  • Shares Repurchased for Q3 2024 was $150.0 million at Jazz Pharmaceuticals, up from $99.8 million in the prior quarter.
  • Over the last five years, Shares Repurchased for JAZZ hit a ceiling of $150.0 million in Q3 2024 and a floor of $7.5 million in Q2 2020.
  • Median Shares Repurchased over the past 3 years was $99.8 million (2023), compared with a mean of $94.1 million.
  • Biggest five-year swings in Shares Repurchased: plummeted 87.5% in 2020 and later soared 101.69% in 2024.
  • Jazz Pharmaceuticals' Shares Repurchased stood at $7.5 million in 2020, then soared by 1233.44% to $99.8 million in 2023, then skyrocketed by 50.31% to $150.0 million in 2024.
  • The last three reported values for Shares Repurchased were $150.0 million (Q3 2024), $99.8 million (Q4 2023), and $74.4 million (Q3 2023) per Business Quant data.